Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China

Ruan, Z; Ung, COL; Shen, Y; Zhang, YW; Wang, WH; Luo, JY; Zou, HM; Xue, Y; Wang, Y; Hu, H; Guo, LX

Hu, H (通讯作者)，Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China.;Hu, H (通讯作者)，Univ Macau, Fac Hlth Sci, Dept Publ Hlth & Med Adm, Macau, Peoples R China.;Guo, LX (通讯作者)，Chinese Acad Med Sci, Beijing Hosp, Natl Ctr Gerontol, Inst Geriatr Med,Dept Endocrinol, Beijing, Peoples R China.

DIABETES THERAPY, 2022; 13 (10): 1737

Abstract

Introduction The objective of the current study was to assess the long-term cost-effectiveness of once-weekly semaglutide 0.5 mg and 1.0 mg versus dul......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索